SOLENO ONE Trademark

Trademark Overview


On Wednesday, November 20, 2024, a trademark application was filed for SOLENO ONE with the United States Patent and Trademark Office. The USPTO has given the SOLENO ONE trademark a serial number of 98863148. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Monday, June 2, 2025. This trademark is owned by Soleno Therapeutics, Inc.. The SOLENO ONE trademark is filed in the Advertising, Business and Retail Services, Insurance & Financial Services, Communication Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Communication services, namely, transmission of information relating to pharmaceuticals, medicine, and medical conditions and diseases via all means of telecommunication including the Internet

Financial administration of patient pharmaceutical reimbursement programs; Financial administration of a patient support and assistance program for obtaining reimbursement for prescription medicines

Business administration of patient pharmaceutical reimbursement programs; Business administration of a patient support and assistance program for obtaining reimbursement for prescription medicines

Providing information in the field of rare diseases and treatment thereof; Providing information in the fields of Prader-Willi syndrome, neurobehavioral diseases, metabolic diseases, endocrine diseases, and diseases characterized by hyperphagia, and the treatment thereof; Pharmaceutical patient support program providing disease awareness and disease management information and materials in the nature of providing a website featuring medical information to improve understanding by patients and caregivers about pharmaceuticals, providing resources to patients in the nature of product information for medical purposes, access to medication, informational materials and information regarding complying with instructions and directions for using medications and medical therapies

Providing a website featuring technology that enables users to access educational and informational materials about medical conditions and diseases, pharmaceutical product and use information, resources for patient support and advocacy programs and treatment affordability programs, and accessing pharmaceuticals; Providing an interactive website that enables users to access educational and informational materials about medical conditions and diseases, pharmaceutical product and use information, resources for patient support and advocacy programs and treatment affordability programs, and accessing pharmaceuticals; Providing online non-downloadable software for users to access educational and informational materials about medical conditions and diseases, pharmaceutical product and use information, resources for patient support and advocacy programs and treatment affordability programs, and accessing pharmaceuticals
soleno one

General Information


Serial Number98863148
Word MarkSOLENO ONE
Filing DateWednesday, November 20, 2024
Status680 - APPROVED FOR PUBLICATION
Status DateMonday, June 2, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesCommunication services, namely, transmission of information relating to pharmaceuticals, medicine, and medical conditions and diseases via all means of telecommunication including the Internet
Goods and ServicesFinancial administration of patient pharmaceutical reimbursement programs; Financial administration of a patient support and assistance program for obtaining reimbursement for prescription medicines
Goods and ServicesBusiness administration of patient pharmaceutical reimbursement programs; Business administration of a patient support and assistance program for obtaining reimbursement for prescription medicines
Goods and ServicesProviding information in the field of rare diseases and treatment thereof; Providing information in the fields of Prader-Willi syndrome, neurobehavioral diseases, metabolic diseases, endocrine diseases, and diseases characterized by hyperphagia, and the treatment thereof; Pharmaceutical patient support program providing disease awareness and disease management information and materials in the nature of providing a website featuring medical information to improve understanding by patients and caregivers about pharmaceuticals, providing resources to patients in the nature of product information for medical purposes, access to medication, informational materials and information regarding complying with instructions and directions for using medications and medical therapies
Goods and ServicesProviding a website featuring technology that enables users to access educational and informational materials about medical conditions and diseases, pharmaceutical product and use information, resources for patient support and advocacy programs and treatment affordability programs, and accessing pharmaceuticals; Providing an interactive website that enables users to access educational and informational materials about medical conditions and diseases, pharmaceutical product and use information, resources for patient support and advocacy programs and treatment affordability programs, and accessing pharmaceuticals; Providing online non-downloadable software for users to access educational and informational materials about medical conditions and diseases, pharmaceutical product and use information, resources for patient support and advocacy programs and treatment affordability programs, and accessing pharmaceuticals

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, November 20, 2024
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, November 20, 2024
Primary Code036
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class038 - Services allowing people to communicate with another by a sensory means.
US Class Codes100, 101, 104
Class Status Code6 - Active
Class Status DateWednesday, November 20, 2024
Primary Code038
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, November 20, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, November 20, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSoleno Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94065

Trademark Events


Event DateEvent Description
Wednesday, March 19, 2025ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, May 14, 2025ASSIGNED TO EXAMINER
Wednesday, November 20, 2024NEW APPLICATION ENTERED
Saturday, April 26, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 20, 2025NON-FINAL ACTION WRITTEN
Tuesday, May 20, 2025NON-FINAL ACTION E-MAILED
Tuesday, May 20, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 21, 2025EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Wednesday, May 21, 2025EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Wednesday, May 21, 2025COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Monday, June 2, 2025ASSIGNED TO LIE
Monday, June 2, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 2, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 21, 2025NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Wednesday, May 21, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 2, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE